Botulinum toxin-A for the treatment of overactive bladder: UK contributions

BACKGROUND: Botulinum toxin-A (BoNT/A) is now established second-line management for refractory overactive bladder (OAB) and recognised in many incontinence guidelines and pathways. For those with neurogenic detrusor overactivity secondary to spinal cord injury or multiple sclerosis, the toxin is cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Seth, JH, Dowson, C, Khan, MS, Panicker, JN, Fowler, CJ, Dasgupta, P, Sahai, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467228/
https://www.ncbi.nlm.nih.gov/pubmed/26097709
http://dx.doi.org/10.1177/2051415812473096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467228/
https://www.ncbi.nlm.nih.gov/pubmed/26097709
http://dx.doi.org/10.1177/2051415812473096

Ejemplares similares